ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Faculty Opinions recommendation of A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718026292.793481389
◽
2013
◽
Author(s):
Steve Plaxe
◽
Kristy Ward
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
◽
Conditionally Replicative Adenovirus
Start Chat
Download Full-text
Related Documents
Cited By
References
A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
Gynecologic Oncology
◽
10.1016/j.ygyno.2013.06.003
◽
2013
◽
Vol 130
(3)
◽
pp. 518-524
◽
Cited By ~ 52
Author(s):
Kenneth H. Kim
◽
Igor P. Dmitriev
◽
Souheil Saddekni
◽
Elena A. Kashentseva
◽
Raymond D. Harris
◽
...
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
◽
Conditionally Replicative Adenovirus
Start Chat
Download Full-text
Faculty of 1000 evaluation for A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718026292.793481332
◽
2013
◽
Author(s):
Paul Sabbatini
◽
Roisin O'Cearbhaill
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
◽
Conditionally Replicative Adenovirus
Start Chat
Download Full-text
1105. A Phase I Clinical Trial of an IL-12 Gene Plasmid Formulated with a Novel Lipopolymeric Gene Delivery System for Intraperitoneal Treatment of Recurrent Ovarian Cancer
Molecular Therapy
◽
10.1016/j.ymthe.2006.08.1210
◽
2006
◽
Vol 13
◽
pp. S425
Author(s):
Ronald D. Alvarez
◽
Mack N. Barnes
◽
Connie McCombs
◽
Sharmila Makhija
◽
Jason Fewell
◽
...
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Gene Delivery
◽
Phase I
◽
Delivery System
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
◽
Gene Delivery System
◽
Intraperitoneal Treatment
Start Chat
Download Full-text
Identifying the Safety Profile of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Anticipation of a Phase I Clinical Trial in Patients with Recurrent Ovarian Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-08-3354
◽
2009
◽
Vol 15
(12)
◽
pp. 4131-4137
◽
Cited By ~ 16
Author(s):
Kellie Matthews
◽
Patricia E. Noker
◽
Baohong Tian
◽
Sheila D. Grimes
◽
Ronna Fulton
◽
...
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Safety Profile
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
Start Chat
Download Full-text
Faculty Opinions recommendation of Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.2001958.1570057
◽
2010
◽
Author(s):
Steve Plaxe
◽
Edwin Alvarez
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
Start Chat
Download Full-text
A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-17-3055
◽
2018
◽
Vol 24
(10)
◽
pp. 2285-2293
◽
Cited By ~ 26
Author(s):
Daniela Matei
◽
Sharad Ghamande
◽
Lynda Roman
◽
Angeles Alvarez Secord
◽
John Nemunaitis
◽
...
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Clinical Pharmacokinetic
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
◽
Platinum Resistant
Start Chat
Download Full-text
A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer
Journal of Translational Medicine
◽
10.1186/1479-5876-10-157
◽
2012
◽
Vol 10
(1)
◽
Cited By ~ 69
Author(s):
Lana E Kandalaft
◽
Daniel J Powell
◽
George Coukos
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
T Cells
◽
Phase I
◽
Adoptive Transfer
◽
Folate Receptor
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
◽
Folate Receptor Alpha
◽
Receptor Alpha
Start Chat
Download Full-text
Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer
Gene Therapy
◽
10.1038/gt.2009.159
◽
2009
◽
Vol 17
(3)
◽
pp. 360-369
◽
Cited By ~ 66
Author(s):
K Anwer
◽
M N Barnes
◽
J Fewell
◽
D H Lewis
◽
R D Alvarez
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
Start Chat
Download Full-text
Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer
Anti-Cancer Drugs
◽
10.1097/cad.0b013e32834ea5d0
◽
2012
◽
Vol 23
(3)
◽
pp. 321-325
◽
Cited By ~ 3
Author(s):
Jong Ha Hwang
◽
Heon Jong Yoo
◽
Myong Cheol Lim
◽
Sang-Soo Seo
◽
Sang-Yoon Park
◽
...
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Phase I Clinical Trial
◽
Oral Etoposide
◽
Platinum Resistant
Start Chat
Download Full-text
A phase I clinical trial of intraperitoneal thiotepa for refractory ovarian cancer
Gynecologic Oncology
◽
10.1016/0090-8258(90)90136-9
◽
1990
◽
Vol 36
(3)
◽
pp. 331-334
◽
Cited By ~ 6
Author(s):
Saeeda Kirmani
◽
Lori McVey
◽
David Loo
◽
Stephen B. Howell
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Phase I Clinical Trial
Start Chat
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close